1033:HKEXSinopec Oilfield Service Corporation Analysis
Data as of 2026-03-17 - not real-time
HK$1.04
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical snapshot: The 20‑day SMA (1.104) sits comfortably above the 50‑day (0.94) and 200‑day (0.807) averages, signaling a bullish backdrop, yet the MACD line is below its signal (bearish) and the histogram is negative, suggesting short‑term weakness. RSI hovers at 48.6, indicating a neutral momentum, while volume is on the rise and 30‑day volatility spikes above 120%, pointing to a highly erratic price environment.
Fundamental outlook: Valuation appears stretched – the trailing P/E of 26 exceeds the industry average of 22.6 and the consensus target price (HK$1.016) is ~2% below the current level (HK$1.04). Profitability is thin (gross margin 8%, net margin <1%) and leverage is extreme, with a debt‑to‑equity ratio over 300 and cash covering only ~16% of total debt. The company pays no dividend, ROE is modest at 6.7%, and the Fear & Greed Index sits at an “Extreme Greed” 81.3, hinting at possible market over‑optimism.
Fundamental outlook: Valuation appears stretched – the trailing P/E of 26 exceeds the industry average of 22.6 and the consensus target price (HK$1.016) is ~2% below the current level (HK$1.04). Profitability is thin (gross margin 8%, net margin <1%) and leverage is extreme, with a debt‑to‑equity ratio over 300 and cash covering only ~16% of total debt. The company pays no dividend, ROE is modest at 6.7%, and the Fear & Greed Index sits at an “Extreme Greed” 81.3, hinting at possible market over‑optimism.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD divergence
- Target price below current market
- Elevated short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- High leverage and thin margins
- Valuation still above peers
- Increasing trading volume supporting liquidity
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Structural debt burden limiting upside
- Flat revenue growth and cyclical sector exposure
- Absence of dividend reduces income appeal
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin0.77%
P/E Ratio26.0
ROE6.73%
ROA1.73%
Debt/Equity316.44
P/B Ratio1.8
Op. Cash FlowHK$7.8B
Free Cash FlowHK$462.6M
Industry P/E22.6
Technical Analysis
TrendBullish
RSI48.6
SupportHK$0.89
ResistanceHK$1.88
MA 20HK$1.10
MA 50HK$0.94
MA 200HK$0.81
MACDBearish
VolumeIncreasing
Fear & Greed Index81.32
Valuation
Target PriceHK$1.02
Upside/Downside-2.33%
GradeOvervalued
TypeValue
Risk Assessment
Beta-0.03
Volatility122.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.